Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei — Stella

Home/Pseudomyxoma Peritonei/

View on ClinicalTrials.gov

Recruiting

Back to Pseudomyxoma Peritonei trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

Norway

Oslo University Hospital HF, Radium, Oslo, Oslo

Key details

Phase

Very early testing

Sponsor

Oslo University Hospital

Collaborators

BeiGene

Enrollment target

~10 participants

Started

October 2025

Primary completion

December 2029

Age range

18 Years and older

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated January 2026